S.T. GENESIS

Serial Number 88848838
602

Registration Progress

Application Filed
Mar 26, 2020
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

S.T. GENESIS

Basic Information

Serial Number
88848838
Filing Date
March 26, 2020
Abandonment Date
November 26, 2021
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Dec 6, 2021
Classes
010

Rights Holder

Speranza Therapeutics, Inc.

03
Address
433 Plaza Real, Suite 275
Boca Raton, FL 33432

Ownership History

Speranza Therapeutics, Inc.

Original Applicant
03
Boca Raton, FL

Legal Representation

Attorney
Joseph J Villapol

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

16 events
Date Code Type Description Documents
Dec 6, 2021 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Dec 6, 2021 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Nov 15, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
May 24, 2021 CNFR R FINAL REFUSAL WRITTEN Loading...
May 24, 2021 GNFR O FINAL REFUSAL E-MAILED Loading...
May 24, 2021 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Mar 30, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 30, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 29, 2021 ALIE A ASSIGNED TO LIE Loading...
Dec 24, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 24, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 24, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 24, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 17, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 31, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 30, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 010
Non-implantable nerve stimulator apparatus, namely, a percutaneous nerve field stimulator for opioid withdrawal and for pain management, namely, pain associated with neurological and autoimmune conditions, back and cervical conditions, Parkinson's Disease and migraine headaches
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
SPERANZA THERAPEUTICS GENESIS

Classification

International Classes
010